GSK: Swine flu will boost Glaxo Smith Kline (GSK)

GSK better known as Glaxo Smith Kline is the producer of a flu vaccine called Relenza. Recent news reports that in Mexico, there is an outbreak of the swine flu which is a virus transported usually in pigs. The virus has mutated and is now affecting many people in mexico as well as in the U.S., and other places. Roche and GSK are the two companies who produce the vaccination for this type of flu. The more news we hear about the swine flu, the more people will start to look to their doctors for Relenza or the other vaccine. This will in turn drive major sales to Glaxo Smith Kline and be posting profits for their bottom line. Their is only a limited amount of the vaccine available and the swine flu is spreading and has the potential to be a full blown epidemic if not contained right away. Swine flu is a major disease that is fatal, and hopefully GSK will help to put it to an end with their vaccine Relenza.